Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months.
Aina Moll-UdinaInés HernanzMaite Sainz-de-la-MazaLaura PelegrínAna Isabel Coelho-BorgesMarta PazosAlfredo AdánVictor LlorençPublished in: International ophthalmology (2023)
The FAc implant is safe and effective at treating NIU over 12 months in a real-world setting in Spain.